StockData
OnKure Therapeutics, Inc. logo

OnKure Therapeutics, Inc. (OKUR) stock

OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$2.82+0.24 (+9.30%)

Close on Nov 18, 2026Market cap $114.20MP/E –Yield –

OnKure Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2024 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2024Dec 31, 2024$0–

More OnKure Therapeutics figures

See a number that looks wrong?